Skip to main content
. Author manuscript; available in PMC: 2008 Apr 30.
Published in final edited form as: J Card Fail. 2007 May;13(4):312–317. doi: 10.1016/j.cardfail.2007.01.006

Table 3.

Ventriculographic and Echocardiographic Measures Obtained Just Prior to CSD Implantation (Pre-treatment) and at the End of Follow-Up (Post-treatment) in CSD-Treated Dogs.

Moderate HF (n=6) Advanced HF (n=6)
Pre-treatment Post-treatment Pre-treatment Post-treatment
LV EF (%) 34±1 42±1* 25±1 27±1
LAVmax (ml) 22.37±1.44 19.50±0.74* 28.42±1.58 28.05±1.63
LAVp (ml) 16.47±0.99 13.75±1.02* 21.10±1.4 20.35±0.79
LAVmin (ml) 14.35±1.02 11.65±0.94* 19.00±1.20 17.67±0.82
LAAEV (ml) 2.12±0.19 2.10±0.11 2.12±0.2 2.70±0.24
LAAEF (%) 13.17±1.38 15.02±0.8 9.98±0.77 13.12±1.28

Abbreviations as in Table 1.

*

p<0.05 vs. Pre-treatment.